Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...